Vimarsana
Biggest News Aggregation in the World

Page 3 - Nasdaq Prof News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Prof. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Prof Today - Breaking & Trending Today

Raymond James Weighs in on Profound Medical Corp.'s FY2027 Earnings (NASDAQ:PROF) - Vimarsana News

Raymond James Weighs in on Profound Medical Corp.'s FY2027 Earnings (NASDAQ:PROF)

Profound Medical Corp. (NASDAQ:PROF – Get Rating) – Analysts at Raymond James issued their FY2027 earnings per share (EPS) estimates for Profound Medical in a research note issued on Thursday, June 15th. Raymond James analyst R. Sarugaser forecasts that the company will post earnings of $2.87 per share for the year. Raymond James currently has […]

Raymond James Boosts Profound Medical (NASDAQ:PROF) Price Target to $20.00 - Vimarsana News

Raymond James Boosts Profound Medical (NASDAQ:PROF) Price Target to $20.00

Profound Medical (NASDAQ:PROF – Get Rating) had its target price boosted by Raymond James from $17.00 to $20.00 in a report published on Monday morning, BayStreet.CA reports. They currently have a strong-buy rating on the stock. Separately, Jefferies Financial Group lowered shares of Profound Medical from a buy rating to a hold rating and boosted […]

Profound Medical (PROF) Set to Announce Quarterly Earnings on Wednesday - Vimarsana News

Profound Medical (PROF) Set to Announce Quarterly Earnings on Wednesday

Profound Medical (NASDAQ:PROF – Get Rating) is scheduled to be posting its quarterly earnings results after the market closes on Wednesday, May 10th. Analysts expect Profound Medical to post earnings of ($0.32) per share for the quarter. Profound Medical (NASDAQ:PROF – Get Rating) last released its quarterly earnings data on Tuesday, March 7th. The company […]

Source: wkrb13.com
Profound Medical (NASDAQ:PROF) Cut to Hold at Jefferies Financial Group - Vimarsana News

Profound Medical (NASDAQ:PROF) Cut to Hold at Jefferies Financial Group

Jefferies Financial Group cut shares of Profound Medical (NASDAQ:PROF – Get Rating) from a buy rating to a hold rating in a report published on Tuesday, Marketbeat.com reports. The brokerage currently has $10.00 target price on the stock, up from their prior target price of $5.50. Jefferies Financial Group also issued estimates for Profound Medical’s […]

Brokerages Anticipate Profound Medical Corp. (NASDAQ:PROF) Will Announce Quarterly Sales of $2.00 Million - Vimarsana News

Brokerages Anticipate Profound Medical Corp. (NASDAQ:PROF) Will Announce Quarterly Sales of $2.00 Million

Equities research analysts predict that Profound Medical Corp. (NASDAQ:PROF – Get Rating) will report $2.00 million in sales for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimates for Profound Medical’s earnings. Profound Medical reported sales of $2.63 million in the same quarter last year, which indicates a negative year […]